Trajectory of blood pressure after initiating anti-calcitonin gene-related peptide treatment of migraine: a target trial emulation from the veterans health administration

被引：0
|
作者：
Kaicheng Wang
Brenda T. Fenton
Vinh X. Dao
Alexander B. Guirguis
Sarah E. Anthony
Melissa Skanderson
Jason J. Sico
机构：
[1] Headache Centers of Excellence,Department of Veterans Affairs, Research, Education, Evaluation and Engagement Activities Center for Headache
[2] Yale School of Public Health,Yale Center for Analytical Sciences
[3] VA Connecticut Healthcare System,Pain Research, Informatics, Multi
[4] VA Minneapolis Health Care System,Morbidities, and Education Center
[5] VA Minneapolis Health Care System,Pharmacy Benefits Management Services
[6] VA Connecticut Healthcare System,Headache Center of Excellence
[7] VA Connecticut Healthcare System,Pharmacy Benefits Management Services
[8] Yale School of Medicine,Headache Center of Excellence
[9] Yale School of Medicine,Department of Neurology
来源：
The Journal of Headache and Pain | / 24卷
关键词：
Anti-CGRP; Blood pressure; Hypertension; Migraine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 34 条
  • [21] Machine-learning-based approach for predicting response to anti-calcitonin gene-related peptide (CGRP) receptor or ligand antibody treatment in patients with migraine: A multicenter Spanish study
    Gonzalez-Martinez, Alicia
    Pagan, Josue
    Sanz-Garcia, Ancor
    Garcia-Azorin, David
    Samuel Rodriguez-Vico, Jaime
    Jaimes, Alex
    Gomez Garcia, Andrea
    Diaz de Teran, Javier
    Gonzalez-Garcia, Nuria
    Quintas, Sonia
    Belascoain, Rocio
    Casas Limon, Javier
    Latorre, German
    Calle de Miguel, Carlos
    Sierra, Alvaro
    Luis Guerrero-Peral, Angel
    Trevino-Peinado, Cristina
    Beatriz Gago-Veiga, Ana
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (10) : 3102 - 3111
  • [22] Nonspecific oral medications versus anti-calcitonin gene-related peptide monoclonal antibodies for migraine: A systematic review and meta-analysis of randomized controlled trials
    Robblee, Jennifer
    Hakim, Sameh M.
    Reynolds, John M.
    Monteith, Teshamae S.
    Zhang, Niushen
    Barad, Meredith
    HEADACHE, 2024, 64 (05): : 547 - 572
  • [23] Comparison of Early-onset Efficacy of Anti-calcitonin Gene-related Peptide Monoclonal Antibodies for Patients with Migraine in Real-world Clinical Practice: Study Protocol for an Exploratory Clinical Trial
    Tanei, Takafumi
    Maesawa, Satoshi
    Nishimura, Yusuke
    Ishizaki, Tomotaka
    Nagashima, Yoshitaka
    Hashida, Miki
    Yamamoto, Shun
    Ando, Masahiko
    Kuwatsuka, Yachiyo
    Hashizume, Atsushi
    Wakabayashi, Toshihiko
    Saito, Ryuta
    NEUROLOGIA MEDICO-CHIRURGICA, 2025, 65 (02) : 71 - 80
  • [24] Comparison of Treatment Patterns in Patients with Migraine Initiating Calcitonin Gene-Related Peptide Monoclonal Antibodies: A Retrospective Real-World US Study
    Varnado, Oralee J.
    Brady, Brenna L.
    Zagar, Anthony J.
    Robles, Yvonne P.
    Hoyt, Margaret
    PATIENT PREFERENCE AND ADHERENCE, 2024, 18 : 69 - 88
  • [25] Switching from ligand to receptor anti-calcitonin gene-related peptide (CGRP) antibodies or vice versa in non-responders: A controlled cohort study
    van Veelen, Nancy
    van Der Arend, Britt W. H.
    Hiele, E.
    van Zwet, E. W.
    Terwindt, Gisela M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2024,
  • [26] Inpatient Constipation Among Migraine Patients Prescribed Anti-calcitonin Gene-Related Peptide Monoclonal Antibodies and Standard of Care Antiepileptic Drugs: A Retrospective Cohort Study in a United States Electronic Health Record Database
    Chomistek, Andrea K.
    Hoffman, Veena
    Urman, Robert
    Gill, Karminder S.
    Ezzy, Stephen M.
    Zhou, Li
    Park, Andrew S.
    Loop, Brett
    Lopez-Leon, Sandra
    McAllister, Peter
    Wang, Florence T.
    PAIN AND THERAPY, 2022, 11 (04) : 1415 - 1437
  • [27] Inpatient Constipation Among Migraine Patients Prescribed Anti-calcitonin Gene-Related Peptide Monoclonal Antibodies and Standard of Care Antiepileptic Drugs: A Retrospective Cohort Study in a United States Electronic Health Record Database
    Andrea K. Chomistek
    Veena Hoffman
    Robert Urman
    Karminder S. Gill
    Stephen M. Ezzy
    Li Zhou
    Andrew S. Park
    Brett Loop
    Sandra Lopez-Leon
    Peter McAllister
    Florence T. Wang
    Pain and Therapy, 2022, 11 : 1415 - 1437
  • [28] Patient characteristics and treatment utilization among patients with migraine initiating self-injectable calcitonin gene-related peptide monoclonal antibody and novel acute medication
    Varnado, Oralee J.
    Hoyt, Maggie
    Ye, Wenyu
    Nicholson, Robert
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (08) : 1451 - 1457
  • [29] Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
    Sun, Wenfang
    Li, Yali
    Xia, Binbin
    Chen, Jing
    Liu, Yang
    Pang, Jingyao
    Liu, Fang
    Cheng, Hua
    FRONTIERS IN PHARMACOLOGY, 2024, 14
  • [30] Treatment patterns for patients initiating novel acute migraine specific medications (nAMSMs) in the context of monoclonal antibodies (mAbs) targeting the calcitonin gene-related peptide (CGRP) pathway
    Zifan Zhou
    Robert Urman
    Karminder Gill
    Andrew S. Park
    Fiston Vuvu
    Leah B. Patel
    Jingsong Lu
    Rolin L. Wade
    Lindsay Frerichs
    Mark E. Bensink
    The Journal of Headache and Pain, 24
1234